Mea i loa ke ehuehu o ka pilikia o ka oi ke kaupaonaʻana, ike pehea i kekahi manawa ia mea paakiki i ka pakele ana o kilograms loaa ka wa makahiki o ka poʻeʻilihune aiʻano a me ka nele o ka hoʻokō. Akā, inā 'oe e manao, e lilo ke kaupaonaʻana, e hiki ke kōkua ole wale haʻahaʻa-calorieʻai hoʻi, i mea nō paʻakikī e malama, akā, i mea hoʻonui, i loko o ka assortment nui mōhai i loko o keʻena kūʻai lāʻau lapaʻau, a ola ai papa kāwiliʻai. I kēia mau lā mākou e kālele ana ma luna o ka 'inikua hoomakaukau "Goldline". Reviews o nā kauka, haku mele 'ana,' ano, a me ka 'ike ma luna o kēia lāʻau lapaʻau huahana hiki ke loaʻa i loko o kā mākou' atikala. E hoʻomanaʻoʻoukou i ka hōʻike i kēia mau papa no ka hoʻohana wale i ka ka poe i ke kino nuipa inideka (BMI) oi ma mua o ka 27, i ka mea, ina e pono e wehe i ka 3-5 kg hope o ka loa kaupaona oiai ka malama ana i kou BMI mea i loko o oluolu kūmau, a 'aʻole' oe i kaʻike, "obesity", alaila, lawe i ka lāʻau 'hiki ole ia. Mea hoʻonui "Goldline", hōʻike manaʻo i ke kauka o ka i mea maikaʻi i loko o hua'ōlelo o ka laulā, pono e hoʻohana 'ia ma lalo o' inikua hooponopono i loko o ka huipūʻana me ka paipaiʻai. Hoʻomanawanui iki mai a hiki i ka nui loa kino paona lilo o 5-15 kg hōʻike, akā, i ka mea ia manawa, kauka ao aku i ka lāʻau i ka nui helu o contraindications (ka mea e e helu 'ia ma lalo nei), no ka mea, o ka i kona kuai ua banned i loko o ka United States, Canada a me Australia. Ma Rusia, ka mea, ua i kuai lilo o ka 'elele i loaʻa, a laila hoʻokuʻu aʻela i loko o keʻena kūʻai lāʻau lapaʻau e kuhikuhi wale.
Uluwehi no ke kaupaona poho "Goldline": hōʻike manaʻo o nā kauka, ka haku mele 'ana a me nā' ano
I ka papa kuhikuhiEʻeleu 'Oponopono o ka lāʻau - sibutramine (sibutramine hydrochloride monohydrate) - mea he nui loa aku kou mana ikaika loa ka makemake mea hoʻokonukonu. Keia kanawai ua loaʻa ma ka accelerating i ke kala o ka serotonin, i ua i kapaia o "hōmona o ka makemake", i mea oe eʻaʻole makemake ke kumu i ka ai, e emi i kouʻono no kaʻai waiwai i loko o carbohydrates, e like me ka ole ma metabolic keʻano o ka hanaʻana i loko o ke kino. Oil, e hele mai ana, mai ka ai, e mahaeʻana, a me ka ikehu e ua kuu i ka ia manawa, 'Imi hoʻohana ma ke kino, a me ka'aʻaʻa ka nui maʻalahi e hoʻohana monakō koko. A, sibutramine ho'ēmi i kā ka nui o nā palapala naʻokoko i loko o ke kino i ka mea ia manawa kōkua e hoʻonui i ka uku o ka pono keia mau mea, a ua 'Imi' ole i loko o ka pūnao. Kēia lāʻau mea i loaʻa i loko o capsules o 10 a me 15 mg, i ka aina o ke kumu - India. i Analogs o keia k e ikeia ai ' "Reduxine", "Obestat", "Lindaksa" a me ka "Meridia". A pau o kēia mau lapaʻauʻiaʻeleu waiwai ua ua sibutramine i oleloia. Laʻau heluna E e pōpilikia e kou kauka, ke mau hoike, ua like penei: hoʻomaka lawe paipai 10 mg kela la i keia (1 papa), a ina he mea kekahi tolerability maikai o kaʻeleu waiwai, hoonui i ka mahele lāʻau a hiki i 15 mg no ka lā. Inā ka lapaʻauʻia,ʻaʻole i hana, i mea, i ka hoʻomanawanui i ke emi ma ke kino paona a kaumaha poho ka loa lohi (emi o 2 kg no 4 pule), i ka hiki aku o ka lāʻau i ana kahuli. Akā, i kēia hana he uuku ke kuka. Aka, no ke aha la, i loko o kēia mau mana a pau o ka ai 'no ke kaupaona poho "Goldline" pane mai o na kahuna lapaau e pili ana i ia lāʻuʻumi iho i (ma ka hua'ōlelo o ka hopena ma luna o ke ola o ke kino)? A, kekahi ikaika e ku e ia kona hoʻohanaʻia e nā mea maʻi e loaa ana mai ka obesity. Ka nui, e hoike ana, e like me ua oleloia, ua k i he nui helu o contraindications a me kaʻaoʻao waiwai, a i malama ma kaʻaneʻane a pau ka poe e hoʻohana i ka waiʻona. No laila, i ka lāʻau "Goldline"ʻai, a hōʻike manaʻo i paʻipaʻiʻia,ʻaʻole naʻe i ka hapa nui o nā mea i paneʻia kōkua loaʻa kilakila hualoaʻa (kekahi nalowale, a me ka 5, 10, 20 a me 30 kg o ke kaumaha i loko o na malama eono), akā, ke kumu nui discomfort i ka? Eaia.
Sibutramine: contraindications a me kaʻaoʻao mau waiwai, (no ka laʻana, "Goldline" hoomalolo)
Mua oe hoʻomaka i ke kaʻina hana o ke kaupaonaʻana poho ka hoʻohana 'ana i kēia k, malama heluhelu i ka papa inoa o nā maʻi a me nā kumu i loko o i sibutramine ua pololei papaia:
- hypersensitivity i ka lāʻau;
- ke alohaʻano obesity i loko o ka hoomanawanui;
- imua o ka anorexia paha bulimia;
- kekahi noʻonoʻo mai;
- Tourette ka maʻi pale;
- naau maʻi (coronary, e hemahema, arrhythmia, naau maʻi, a me ka helu o nā 'ē aʻe);
- tachycardia;
- ʻike ākea artery maʻi;
- pilikia me ka cerebral holo;
- hihia hoʻi akepaʻa a me nā konāhua ho'āʻo;
- glaucoma;
- lāʻau 'a me ka lama.
Nō hoʻi, aia nō i ka helu o kaʻaoʻao ole:
- pinepine headaches, Kanikani'āʻula, pōniuniu, restlessness;
- naau palpitations;
- maloo waha;
- he piha lilo o ka ikaika loa ka makemake;
- pilikia a me ka gastrointestinal'āpana: constipation, diarrhea, nausea.
Mau mea na contraindications a me kaʻaoʻao mau waiwai i sibutraminosoderzhaschie ai ', a, ma ka hana,' o ia hoʻi "Goldline". ʻai huaale nāʻana, hoakaka, a me ka haku mele 'ana o ka a mākou nānā' ana ma o ka 'atikala, e pono poe i keʻena kūʻai lāʻau lapaʻau. No laila, ma mua hoʻohanaʻai huaale "Goldline", "Reduxine" a me ka e like, eʻoiaʻiʻo, e hooholo pu me kou kauka, ia mea e pono ai oe. Keu kaupaona no i kekahi wā o ka haʻalele i kou kino ka wā e hoʻomaka e noho ai ke ola i ke ola, e malama haʻahaʻa-calorieʻai ai wale olalo i ka 'O ke kaulike no kou kino, e like me ka pono me ka haʻuki. E hoomanao i oe i kekahi ola kino, a hoihoi aku i ke kino nei,ʻaʻole pēlā oluolu ma hope o ka hiki hopena o ka loaa ana potent ai '.